# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-123263
Filing Date
2020-04-28
Accepted
2020-04-28 16:58:35
Documents
22
Period of Report
2020-05-13
Effectiveness Date
2020-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d868307ddef14a.htm | DEF 14A | 778872
2 | DEF 14A | d868307ddef14a1.pdf | DEF 14A | 300102
3 | GRAPHIC | g868307dsp003a.jpg | GRAPHIC | 1788
4 | GRAPHIC | g868307dsp003b.jpg | GRAPHIC | 1762
5 | GRAPHIC | g868307dsp003c.jpg | GRAPHIC | 2243
6 | GRAPHIC | g868307dsp010a.jpg | GRAPHIC | 44703
7 | GRAPHIC | g868307dsp010b.jpg | GRAPHIC | 34967
8 | GRAPHIC | g868307dsp011.jpg | GRAPHIC | 34602
9 | GRAPHIC | g868307dsp044.jpg | GRAPHIC | 67598
10 | GRAPHIC | g868307dsp097.jpg | GRAPHIC | 36601
11 | GRAPHIC | g868307g01p86.jpg | GRAPHIC | 91423
12 | GRAPHIC | g868307g11x62.jpg | GRAPHIC | 30959
13 | GRAPHIC | g868307g12b75.jpg | GRAPHIC | 12826
14 | GRAPHIC | g868307g12c98.jpg | GRAPHIC | 11781
15 | GRAPHIC | g868307g12d68.jpg | GRAPHIC | 11374
16 | GRAPHIC | g868307g13a62.jpg | GRAPHIC | 13668
17 | GRAPHIC | g868307g13b55.jpg | GRAPHIC | 10666
18 | GRAPHIC | g868307g13c23.jpg | GRAPHIC | 11172
19 | GRAPHIC | g868307g13d56.jpg | GRAPHIC | 12448
20 | GRAPHIC | g868307g34g49.jpg | GRAPHIC | 117104
21 | GRAPHIC | g868307g35j52.jpg | GRAPHIC | 102660
22 | GRAPHIC | g868307g50k05.jpg | GRAPHIC | 11394
| Complete submission text file | 0001193125-20-123263.txt |  | 2097436

Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-14656 | Film No.: 20825887
SIC: 2836 Biological Products, (No Diagnostic Substances)